NEW YORK (360Dx) – Saladax Biomedical today announced an agreement to acquire the exclusive patent rights for antipsychotic drug tests from Janssen Pharmaceutica.

Saladax will have the patent rights to Janssen Pharmaceutica's diagnostic tests that determine drug levels in patients undergoing treatment with antipsychotic drugs. Financial and other terms of the deal were not disclosed.